Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 153.27
-0.013 %
$ 15.5 B
Market Cap
40.87
P/E
NBIX - CASH & EQUIVALENTS
Cash & Equivalents NBIX - Neurocrine Biosciences, Inc.
251 M
LAST VALUE
-14.16%
2 YEAR CAGR
12.12%
5 YEAR CAGR
18.81%
10 YEAR CAGR